PriceTargets.com logo

Abpro - ABP Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 1,619.69%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.23 As of 05/1/2025 02:06 PM ET
▼ -0.0062 (-2.60%)

This chart shows the closing price for ABP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
MarApr$0.24Closing price on 04/30/25:
Get New Abpro Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ABP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABP

Analyst Price Target is $4.00
▲ +1,619.69% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Abpro in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 1,619.69% upside from the last price of $0.23.

This chart shows the closing price for ABP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
11/242/254/255/26$0.16$1.36$2.55$3.74$4.94Closing price on 04/30/25: $0.24High$4.00Average$4.00Low$4.00




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in Abpro.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/6/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/4/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2025

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/24/2025Maxim GroupInitiated CoverageBuy$4.00
(Data available from 5/1/2020 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/3/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/2/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/1/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2025

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Abpro logo
Abpro Holdings Inc. is a biotechnology company. The company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc., formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.
Read More

Today's Range

Now: $0.23
Low: $0.23
High: $0.26

50 Day Range

MA: $0.41
Low: $0.23
High: $0.76

52 Week Range

Now: $0.23
Low: $0.22
High: $13.00

Volume

242,532 shs

Average Volume

198,041 shs

Market Capitalization

$12.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Abpro?

The following Wall Street sell-side analysts have issued stock ratings on Abpro in the last year: Maxim Group.
View the latest analyst ratings for ABP.

What is the current price target for Abpro?

0 Wall Street analysts have set twelve-month price targets for Abpro in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 1,619.7%. Maxim Group has the highest price target set, predicting ABP will reach $4.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $4.00 for Abpro in the next year.
View the latest price targets for ABP.

What is the current consensus analyst rating for Abpro?

Abpro currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABP will outperform the market and that investors should add to their positions of Abpro.
View the latest ratings for ABP.

What other companies compete with Abpro?

Other companies that are similar to Abpro include Gain Therapeutics, Kronos Bio, Medicus Pharma, Renovaro and OKYO Pharma. Learn More about companies similar to Abpro.

How do I contact Abpro's investor relations team?

Abpro's physical mailing address is 6 ST JOHNS LANE FLOOR 5, NEW YORK NY, 10013. The company's listed phone number is 248-890-7200. The official website for Abpro is www.atlanticcoastalacquisition.com. Learn More about contacing Abpro investor relations.